Efficacy, tolerability and barriers to the use of anti-CGRP medications among migraine patients in Egypt: real world experience

• by Taha, Nourhan Abdelmohsen, Gomaa, Manar Abdelazeem, Helmy, Shahinaz Mohamed, Farag, Sherien Mohamed, Moustafa, Ramez Reda

• June 3, 2026

Aripiprazole as second-line pharmacotherapy for a heterogeneous cohort of refractory functional dizziness disorders: a pilot preliminary retrospective study

• by Fumiyuki Goto, Koichiro Wasano

• June 3, 2026

Medical Oddities: Do Jellyfish Hold a Healing Secret?

Jellyfish, pets, watermelon, brain implants, and fennel fuel this week's surprises.

• by Teraya Smith

• July 1, 2026

• 5 min

Healthcare service provided for headache patients in selected African countries: a cross-sectional survey of clinician perspectives

• by Amr Hassan, Freda Dodd-Glover, Najib Kissani, Magnerou Annick Melanie, Sounga Bandzouzi Prince Eliot Galieni, Mendinatou Agbetou, Kigocha Okeng'o, Daniel Gams Massi, Evelyne Diarra, Agbo Panzo Cedric, Chiamaka Edith Okereke, Wael Alwachi, Osheik Seidi, Kadira Abdi Aden, Augustina Charway-Felli, Emna Ellouz, Foksouna Sakadi, John N. Jabang, Denis Shatima, Athanase Millogo, Ahmed Allioueche, Fatimata Hassane Djibo, Tiwonge Elisa Phiri, Jamal Barros Baco, Grenaba-Duval Lewis Reinier Joël, Frighton Mutete, Doaa M. Khalil, Mona Hussein

• July 15, 2026